Chlorpyrifos Lawsuits Claim Pesticide Caused Brain Damage, Other Injuries for Children

Several lawsuits filed in California state courts last week claim manufacturers of the pesticide chlorpyrifos are placing children at risk of brain damage, autism and other developmental issues.

Chlorpyrifos was introduced to the market in 1965, to control a number of pests, including insects and worms. It has been sold under a variety of brand names, including Dursban, Lorsban, Scout, Empire, Eradex and Warhaw.

Although potential side effects of chlorpyrifos exposure has been a concern for decades, and use of the product in household settings was banned in 2001, the pesticide is still used on more than 40,000 farms in the U.S. on about 50 different types of crops, including almonds and grapes.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

On July 12, four chlorpyrifos lawsuits were filed by in various California state superior courts, each naming Corteva, Inc. and Dow Chemical Company as defendants, and raising similar allegations that their products cause autism, attention deficit disorder and other developmental problems in children.

For example, one complaint (PDF) was filed by Librada Gomez Mendoza, on behalf of herself and her son, Ulysses, indicating he suffered severe neurological injuries after to exposure to chlorpyrifos both in utero and as an infant.

His mother, Mendoza, worked at a packing house in New York City during her pregnancy in 2008, according to the lawsuit, washing and packing peaches, plums and other crops known to be exposed to chlorpyrifos. However, that was just one of many exposures during Ulysses childhood.

After the family moved to Fresno, California, hundreds of pounds of the pesticide were sprayed within two miles of his home, and his uncles did agricultural work in fields where it was sprayed, carrying the chemicals home on their clothing or bodies. The lawsuit also indicates other chlorpyrifos exposures are likely ongoing.

Ultimately, the child was diagnosed with attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), anxiety and learning disabilities.

โ€œThe foreseeable fate and transport of chlorpyrifosโ€ฆonce released into the agricultural community such as Ulyssesโ€™ and his familyโ€™s, are such that hundreds, if not thousands, of families in the general area where Ulysses presently lives who reside in homes that are similarly contaminated,โ€ the lawsuit warns. โ€œWithout remediation of the toxic dust and residues that continue to contaminate Ulyssesโ€™ home there will be a continued, chronic dosing of Ulysses, his siblings and mother, increasing the risk of the serious and life-shortening diseases that are a consequence of their everyday exposure to chlorpyrifos.โ€

All of the plaintiffs are pursuing claims for strict product liability, failure to warn, defective design, negligence, nuisance and trespass, indicating their own children were harmed by chlorpyrifos exposure.

Chlorpyrifos Still On the Market

In July 2019, the EPA made a controversial decision toย allow chlorpyrifos to stay on the marketย in the United States, despite numerous objections and studies linking the pesticide to serious health risks. Since then, several states have either filed complaints against the EPA over the decision, or say they plan to do so.

California has already moved toย ban the pesticide, with restrictions on chlorpyrifos already in effect since January 2019.

In recent months, courts nationwide have seen anย influx of chlorpyrifos lawsuitsย over the alleged side effects of the controversial pesticide.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




1 Comments


Angela
This is terrifying.

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A Georgia couple’s lawsuit claims the makers of Dupixent failed to provide adequate warnings about the risk of mycosis fungoides, a type of T-cell lymphoma.
In a joint statement, plaintiffs and defendants in AngioDynamics port catheter lawsuits have laid guidelines for what types of cases should be selected to serve as potential bellwether trials.
Women who experienced infection, chronic inflammation, implant instability or other complications after internal bra mesh procedures are now questioning whether those risks were fully disclosed before implantation.